Lilly Price Prediction: Case for Double-Digit Upside
Eli Lilly faces a pivotal year as its GLP-1 franchise powers revenue growth and new oral therapies expand addressable...
What is a market index vs economic indicator? This explanation outlines how benchmarks differ from signals and how investors use them together.
27,369 articlesEli Lilly faces a pivotal year as its GLP-1 franchise powers revenue growth and new oral therapies expand addressable...
CrowdStrike just split stock, turning a high-priced share into four easier-to-access pieces. A lower price can spark ...
Legendary investor Michael Burry has taken a direct short against Micron Technology, challenging the view that AI-dri...
Infrastructure software has led gains while traditional apps lag, prompting a reevaluation of winners and laggards. A...
As memory cycles swing, the safest play in July may not be the pure-play chips you expect. This article explains why ...
Salesforce leans on a sweeping buyback to defend its core, while ServiceNow expands through acquisitions focused on s...
Boise remains a retirement magnet, but costs have risen. With a $900K pot, a paid-off home, and careful tax and cash-...
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
As markets rally into mid-2026, analysts spotlight five stock setups where Wall Street sees the most upside, driven b...
Jim Cramer says he cringes at owning AT&T or Verizon as Bernstein flags Starlink competition risk, signaling a potent...
Grab's CEO recently sold 400,000 Class A shares for about $1.6 million. This insider move raises the question: should...
Mid-year, Figma faces a volatile path as investors weigh AI-led growth against high valuation. A refreshed price pred...